News
Teva is among seven drug companies that have filed lawsuits against Medicare price negotiations.
At the top of the list are the popular semaglutides for weight loss, Ozempic, Rybelsus and Wegovy.
Medicaid expansion and high marketplace enrollment are contributing to the numbers, KFF says.
Amazon surfaces eligible benefits to customers when they search for related products or devices.
CEO Andrew Witty promises to pass through 100% of drug rebates to consumers and wants see other companies do the same.
The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds.
The county plans to restore Level II trauma care immediately once it assumes hospital operations, it says.
The health systems, Illumina, and Regeneron have invested $320M in what Truveta calls the largest and most diverse database for patient care.
Overall, these top 25 drugs were responsible for nearly $50 billion in total Medicare Part D spending in 2022, AARP finds.
To reduce unauthorized changes to coverage, the rule expands CMS' authority to immediately suspend an agent or broker.